These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3893841)

  • 1. Clinical pharmacokinetics of bretylium.
    Rapeport WG
    Clin Pharmacokinet; 1985; 10(3):248-56. PubMed ID: 3893841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of bretylium in man after intravenous administration.
    Narang PK; Adir J; Josselson J; Yacobi A; Sadler J
    J Pharmacokinet Biopharm; 1980 Aug; 8(4):363-72. PubMed ID: 7431227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: clinical application of a new assay for bretylium.
    Anderson JL; Patterson E; Wagner JG; Johnson TA; Lucchesi BR; Pitt B
    J Cardiovasc Pharmacol; 1981; 3(3):485-99. PubMed ID: 6168830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and intravenous bretylium disposition.
    Anderson JL; Patterson E; Wagner JG; Stewart JR; Behm HL; Lucchesi BR
    Clin Pharmacol Ther; 1980 Oct; 28(4):468-78. PubMed ID: 7408407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bretylium kinetics in renal insufficiency.
    Josselson J; Narang PK; Adir J; Yacobi A; Sadler JH
    Clin Pharmacol Ther; 1983 Feb; 33(2):144-50. PubMed ID: 6822027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bretylium pharmacokinetics and bioavailabilities in man with various doses and modes of administration.
    Garrett ER; Green JR; Bialer M
    Biopharm Drug Dispos; 1982; 3(2):129-64. PubMed ID: 7104462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of bretylium in dogs and the effect of hemoperfusion on elimination.
    Kamath BL; Gibson TP; Look ZM; McEntegart CM; Comrie EB; Yacobi A
    J Pharm Sci; 1982 Nov; 71(11):1294-6. PubMed ID: 7175729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bretylium tosylate: a review.
    Bryan CK; Darby MH
    Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of [14C]bretylium tosylate in rats.
    Yacobi A; Kamath BL; Lai CM; Stampfli HF
    J Pharm Sci; 1983 May; 72(5):556-9. PubMed ID: 6864505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of [14C]bretylium tosylate in rats.
    Kamath BL; Stampfli HF; Lai CM; Yacobi A
    J Pharm Sci; 1981 Jun; 70(6):667-9. PubMed ID: 7252812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.
    Duchin KL; McKinstry DN; Cohen AI; Migdalof BH
    Clin Pharmacokinet; 1988 Apr; 14(4):241-59. PubMed ID: 3292102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.
    Kearns GL; Young RA
    Clin Pharmacokinet; 1994 Mar; 26(3):169-89. PubMed ID: 8194281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ
    Clin Pharmacokinet; 1986; 11(2):107-32. PubMed ID: 3514043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram for bretylium dosing in renal impairment.
    Adir J; Narang PK; Josselson J
    Ther Drug Monit; 1985; 7(3):265-8. PubMed ID: 4049461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; Pickron J; Goldman AM
    Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.
    Ambrose PJ
    Clin Pharmacokinet; 1984; 9(3):222-38. PubMed ID: 6375931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.